What is the impact of MRD on the management of patients with 𝐹𝐿𝑇3-mutated AML AML Hub 3:28 10 months ago 245 Далее Скачать
Value of MRD in patients with NPM1-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 1:38 3 years ago 483 Далее Скачать
What Is FLT3-Mutated Acute Myeloid Leukemia? Patient Empowerment Network 2:26 1 year ago 533 Далее Скачать
Management & outcome of patients with CBF AML and FLT3-ITD VJHemOnc – Video Journal of Hematology & HemOnc 0:35 1 year ago 210 Далее Скачать
Evaluating the impact of MRD by error-corrected NGS on patients with AML treated with CPX-351 VJHemOnc – Video Journal of Hematology & HemOnc 1:39 10 days ago 38 Далее Скачать
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 1:20 1 year ago 120 Далее Скачать
The management of R/R FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 1:52 2 years ago 66 Далее Скачать
What is FLT3-positive AML? What is gilteritinib? #AML HealthTree University for Blood Cancers 2:43 1 year ago 2 452 Далее Скачать
Continuous treatment with FLT3 inhibitors for patients with FLT3-mutated AML undergoing alloSCT VJHemOnc – Video Journal of Hematology & HemOnc 1:04 5 months ago 103 Далее Скачать
The prognostic value of FLT3-ITD residual disease in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:49 2 years ago 327 Далее Скачать
Impact of MRD on FLT3-ITD AML VJHemOnc – Video Journal of Hematology & HemOnc 2:54 6 years ago 269 Далее Скачать
Current role of MRD in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:12 2 years ago 161 Далее Скачать
QuANTUM-First: FLT3-ITD-specific MRD clearance is associated with improved OS in newly diagnosed AML VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 101 Далее Скачать
How can MRD guide treatment of AML? VJHemOnc – Video Journal of Hematology & HemOnc 1:39 2 years ago 232 Далее Скачать
MRD in AML: What is it and what do I do about it? HMP Education 24:36 6 years ago 7 124 Далее Скачать
Patient-reported outcomes in FLT3-mutated AML patients treated with gilteritinib plus azacitidine VJHemOnc – Video Journal of Hematology & HemOnc 1:28 2 years ago 102 Далее Скачать
MRD negativity assessed by flow cytometry associated with improved outcomes in NPM1-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 3:05 3 years ago 432 Далее Скачать
The 2021 treatment algorithm for FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 6:47 3 years ago 1 701 Далее Скачать
Methods to evaluate MRD in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 140 Далее Скачать
The Importance of the FLT3 Mutation In AML Patient Empowerment Network 3:36 1 year ago 278 Далее Скачать
